Healthcare -
Biotechnology - NASDAQ - US
$ 74.17
1.57 %
$ 9.55 B
Market Cap
-19.52
P/E
PCVX - SHORT-TERM DEBT
Short-term Debt PCVX - Vaxcyte, Inc.
7.11 M
LAST VALUE
-17.90%
2 YEAR CAGR
88.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR